'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial
- PMID: 29530888
- DOI: 10.1161/CIRCOUTCOMES.118.004665
'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial
Erratum in
-
Correction to: Moving the Goalposts Into Unblinded Territory: The Larger Lessons of DEFER and FAME 2 and Their Implications for Shifting End Points in ISCHEMIA ['Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial].Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e000038. doi: 10.1161/HCQ.0000000000000038. Circ Cardiovasc Qual Outcomes. 2018. PMID: 29610248 No abstract available.
Keywords: bias; clinical trials; coronary artery disease; percutaneous coronary intervention.
Comment in
-
The Ultimate Goal Post.Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004744. doi: 10.1161/CIRCOUTCOMES.118.004744. Circ Cardiovasc Qual Outcomes. 2018. PMID: 29610249 No abstract available.
-
Letter by Hochman and Maron Regarding Article, "'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial.".Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004742. doi: 10.1161/CIRCOUTCOMES.118.004742. Circ Cardiovasc Qual Outcomes. 2018. PMID: 29636347 No abstract available.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
